Neil Nagovski MD in Ft Lauderdale, Florida

Home Florida Ft Lauderdale

Neil Nagovski MD has Hematology/oncology as his primary medical specialty. Their primary office is: 4725 N Federal Hwy in Ft Lauderdale, Florida.

They're a part of the: Holy Cross Medical Group medical group which has around 185 members. You can call their office at 954-771-8000 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1993 (around 31 years of experience). They are listed as doing telehealth appointments.

Neil Nagovski MD Office Phone and Directions

Neil Nagovski MD
Holy Cross Medical Group
4725 N Federal Hwy
Ft Lauderdale, Florida 33308
954-771-8000

Patient Ratings
Please rate your experience with Neil Nagovski MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 954-771-8000

Enter a starting address:

Healthcare Info for Neil Nagovski MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1993
The Primary Medical Specialty for Neil Nagovski MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 4486683406
NPI #: 1588635668
NPI Created On: 01/27/2006
NPI Last Updated Listed as: 03/29/2021
Primary Taxonomy Code: 207RH0003X
License Number:
ME106652
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Molina Healthcare of Florida, Inc
Humana
Celtic Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Russian, French.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient, visit typically 25 minutes
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Injection, dexamethasone sodium phosphate, 1 mg
Injection, diphenhydramine hcl, up to 50 mg
Injection, ondansetron hydrochloride, per 1 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788425361

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788425365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788425369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788425373

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818614435

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERBITUX

Open Associated Drug #1: 66733-958-23

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818660225

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERBITUX

Open Associated Drug #1: 66733-958-23

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818660227

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERBITUX

Open Associated Drug #1: 66733-958-23

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: CYRAMZA

Associated Drug #2: 0002-7669-01

Payments Total: $4,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801655361

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $1,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801981909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $4,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 801993579

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Hematology/oncology Professionals in Ft Lauderdale

1.
Mehmet Hepgur MD

1600 S Andrews Ave
Ft-lauderdale, FL
North Broward Hospital District

2.
Shannon Keating

1600 S Andrews Ave
Ft-lauderdale, FL
North Broward Hospital District

3.
Shannon Keating

1625 Se 3rd Ave
Ft-lauderdale, FL
North Broward Hospital District

4.
Alan Grosset MD

1600 S Andrews Ave
Ft-lauderdale, FL
North Broward Hospital District

5.
Archana Maini MD

1330 Se 4th Ave
Ft-lauderdale, FL

6.
Georges Azzi

4725 N Federal Hwy
Ft-lauderdale, FL
Holy Cross Medical Group

Providers in Holy Cross Medical Group

1.Zonia Acosta

4004 N Ocean Blvd
Ft Lauderdale Fl 33308-6420
Holy Cross Medical Group
Internal Medicine

2.Zonia Acosta

4012 N Ocean Blvd
Ft Lauderdale Fl 33308-6420
Holy Cross Medical Group
Internal Medicine

3.Zonia Acosta

1309 S Federal Hwy
Fort Lauderdale Fl 33316-2040
Holy Cross Medical Group
Internal Medicine

4.Gustavo Alameda

4725 N Federal Hwy 504
Ft Lauderdale Fl 33308-4603
Holy Cross Medical Group
Neurology

5.Aldo Alamo

1309 S Federal Hwy
Fort Lauderdale Fl 33316-2040
Holy Cross Medical Group
Internal Medicine

6.Aldo Alamo

5597 N Dixie Hwy
Oakland Park Fl 33334-3406
Holy Cross Medical Group
Internal Medicine

View all 185 members of Holy Cross Medical Group medical group